Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study

Published:2022-07-06 Issue:3 Volume:9 Page:529-537
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Wechsler Maximilian^ORCID,Schwinger Robert H. G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00313-7.pdf

Reference30 articles.

1. Ponikowski P, Voors AA, Anker SCD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.

2. Nieminen MS, Altenberger J, Ben-Gal T, et al. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. Int J Cardiol. 2014;174(2):360–7. https://doi.org/10.1016/j.ijcard.2014.04.111.

3. Abdin A, Bauersachs J, Frey N, et al. Timely and individualized heart failure management: need for implementation into the new guidelines. Clin Res Cardiol. 2021;13:1–9. https://doi.org/10.1007/s00392-021-01867-2.

4. Papp Z, Agostoni P, Alvarez J, et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev. 2020;8(6): e19. https://doi.org/10.15420/cfr.2020.03.eCollection2020Mar.

5. Reuter H, Schwinger RHG. Calcium handling in human heart failure–abnormalities and target for therapy. Wien Med Wochenschr. 2012;162(13–14):297–301. https://doi.org/10.1007/s10354-012-0117-9.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated levosimendan infusions in the management of advanced heart failure: review of the evidence and meta-analysis of the effect on mortality;Journal of Cardiovascular Pharmacology;2023-11-22